Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español
NIDA Home > Medical Consequences of Drug Abuse

Kidney Damage

Picture of kidney

Estimated annual dialysis cost for just one person who has wrecked his own kidneys by shooting heroin ("heroin nephropathy"):  $50,000

Source: A paraphrase from the AMERICAN JOURNAL OF KIDNEY DISEASES, 40(3):611-622, Lee H © 2002 National Kidney Foundation.  

Some drugs may cause kidney damage or failure, either directly or indirectly from dangerous increases in body temperature and muscle breakdown.

 

Drugs that can cause kidney damage:

 

Selected Research Findings on the Mental Health Effects of Drug Abuse

End-Stage Renal Disease and Chronic Kidney Disease in a Cohort of African-American HIV-Infected and At-Risk HIV-Seronegative Participants Followed between 1988 and 2004

HIV-infected African-Americans are at increased risk of end-stage renal disease requiring renal replacement therapy (RRT). This study sought to compare the incidence of RRT in a cohort of 4509 HIV-infected and 1746 HIV-seronegative African-Americans and describe temporal trends in RRT and chronic kidney disease (CKD) in HIV infection. Incident RRT was defined by matching participant identifiers with the US Renal Data System; CKD was defined as an estimated glomerular filtration rate < 60 ml/min per 1.73m for >/= 3 months. Standardized incidence ratios (SIR) and 95% confidence intervals (CI) were calculated by indirect adjustment. Risk factors for RRT were assessed by person-time methods and Poisson regression. RRT was initiated in 24 HIV-seronegative subjects over 13415 person-years of follow-up (SIR, 2.3; 95% CI, 1.5-3.4), in 51 HIV-infected participants without AIDS over 10780 person-years (SIR, 6.9; 95% CI, 5.1-9.0), and in 125 participants with AIDS over 9833 person-years. SIR, 16.1; 95% CI, 13.4-19.2). In HIV-infected African-Americans, RRT incidences were 5.8 and 9.7/1000 person-years in the pre-HAART and HAART eras, respectively (adjusted rate ratio 1.2; 95% CI, 0.8-1.9). In supplementary analyses, CKD incidence declined significantly in the HAART era compared with pre-HAART, but the CKD period prevalence increased. Nearly 1% of HIV-infected African-Americans initiated RRT annually, a rate that was similar in the HAART and pre-HAART eras. However, while new cases of CKD decreased, the prevalence of CKD increased in the HAART era. This increase reflects improvements in survival among individuals with HIV-associated CKD. Lucas, G., Mehta, S., Atta, M., Kirk, G., Galai, N., Vlahov, D., and Moore, R. End-Stage Renal Disease and Chronic Kidney Disease in a Cohort of African-American HIV-Infected and At-Risk HIV-Seronegative Participants Followed between 1988 and 2004. AIDS, 21(18), pp. 2435-2443, 2007.



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment



National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Friday, February 13, 2009. The U.S. government's official web portal